Close Menu

NEW YORK (GenomeWeb) – Cancer Genetics (CGI) reported on Thursday that its third quarter revenues grew 19 percent year over year as the company narrowed its net loss.

For the three months ended Sept. 30, the Rutherford, NJ-based molecular diagnostics firm had revenues of $8.0 million compared to $6.8 million in the year-ago period. Analysts, on average, had expected revenues of $7.9 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.